Riskpilot← Back to searchSign inGet full accessLongevity Plus klinik AB
ABActiveOrg 5594316324StockholmBusiness and other management consultancy activities · NACE 7020Est. 20230 employees
Revenue 2024
SEK 0
EBITDA margin
—
-144% vs 2023
Equity ratio
-6.3%
Financial strength
Net profit 2024
SEK -151K
-885% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -37K | -144% |
| Net profit | SEK -151K | -885% |
| Total assets | SEK 2,2M | +323% |
| Equity | SEK -138K | -1183% |
| Employees | 0 | — |
Legal name
Longevity Plus klinik AB
Org number
5594316324
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
25 april 2023
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska bedriva konsultverksamhet inom hälso- och sjukvård, rehabilitering och longevity-kliniktjänster, innefattande rådgivning, projektledning, utbildning, screening, diagnostik och klinisk verksamhet, samt därmed förenlig verksamhet.
Address
Stockholm
Email
hello@longevity-plus.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 |
|---|---|---|
| Revenue | 0 | 0 |
| Staff expenses | — | — |
| EBITDA | −15 | −37 |
| Depreciation & amort. | — | −88 |
| EBIT | −15 | −125 |
| Net financials | 0 | −25 |
| Profit before tax | −15 | −151 |
| Tax | — | — |
| Net profit | −15 | −151 |
| Item | 2023 | 2024 |
|---|---|---|
| Total assets | 518 | 2 192 |
| Equity | 13 | −138 |
| Long-term debt | — | 2 233 |
| Short-term debt | 505 | 97 |
| Total debt | 505 | 2 330 |
EBITDA margin
-3736800.0%
This company
15.8%
Market median
-23650733% vs market
20232024
Equity ratio
-6.3%
This company
38.2%
Market median
-116% vs market
20232024
Return on equity
-15051900.0%
This company
18.4%
Market median
-81803904% vs market
20232024
Net profit margin
-15051900.0%
This company
8.1%
Market median
-185826026% vs market
20232024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20232024
Debt / equity
16.91×
This company
0.62×
Market median
-2627% vs market
20232024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-04-25 – 2023-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
EA Authorized Recipient of Service | Authorized Recipient of Service | 2025 | — | — |
PJ Chief Auditor | Chief Auditor | 2023 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2023 | — | — | |
| Deputy Board Member | 2025 | — | — | |
| Deputy Board Member | 2023 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2023 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Longevity Plus klinik AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eva Annelie Konradsson | Authorized Recipient of Service | 0 companies |
| Per Johan Anders Strömberg | Chief Auditor | 0 companies |
| Emirhan Yagci | Deputy Board Member | 0 companies |
| Helena B L Sundin | Deputy Board Member | 0 companies |
| Barbro Helena Norén Sundin | Deputy Board Member | 0 companies |
| Carl Martinsson | Board of Directors | 0 companies |
| Murat Yagci | Board of Directors | 0 companies |